Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-11-13
1991-07-02
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544353, 544354, 544355, 544356, A61K 31495, C07D40308, C07D40310, C07D40314
Patent
active
050286064
ABSTRACT:
(1H-azol-1-ylmethyl)substituted quinoxaline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increased proliferation and/or abnormal differentiation of epithelial tissues.
REFERENCES:
patent: 3870718 (1975-03-01), Abuel-Haj
patent: 4756999 (1988-07-01), Swain et al.
patent: 4853400 (1989-08-01), Parsons et al.
patent: 4859684 (1989-08-01), Raeymaekers et al.
Chytil, Pharmacological Reviews, 36, p. 935 (1984).
Elias et al., Arch. Dermatol., 117, p. 160 (1981).
Lotan, Biochimica et Biophysica Acta, 605, p. 33 (1980).
Thomas et al., J. Am. Acad. Dermatol., 4, p. 505 (1981).
Goodman, The New England Journal of Medicine, 16, p. 1023 (1984).
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Sanz Gerard C.
Venet Marc G.
Beinhardt E.
Janssen Pharmaceutica N.V.
Metz Charles J.
Shen Cecilia
LandOfFree
(1H-azol-1-ylmethyl)substituted quinoxaline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (1H-azol-1-ylmethyl)substituted quinoxaline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-azol-1-ylmethyl)substituted quinoxaline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247371